Working… Menu

H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02960230
Recruitment Status : Recruiting
First Posted : November 9, 2016
Last Update Posted : March 11, 2021
The V Foundation for Cancer Research
Pacific Pediatric Neuro-Oncology Consortium
Bristol-Myers Squibb
Information provided by (Responsible Party):
Sabine Mueller, MD, PhD, University of California, San Francisco